Table 1:
Patient Characteristics and Outcomes.
|
Age/Gender Ethnicity |
Clinical Setting and Procedure |
MELD |
HE |
Pre-OLT psychiatric medications |
Pre-OLT % Dose Reduction |
Post-OLT meds |
POD of med restart |
IMS |
Medical LOS (days) |
Outcome And Psych LOS |
A |
58/F Arabic |
Recurrent Allograft HCV OLT |
40 |
Yes |
None |
100% |
Quetiapine 25 mg Ativan 1 mg Haloperidol 2
mg |
1 29 50 |
BAS,
ST, MMF, TAC |
22 |
Psych
Admit 25
days |
B |
58/M Caucasian |
Recurrent
Allograft Cryptogenic OLT |
37 |
Yes |
Olanzapine 2.5 mg Lamotrigine 25 mg |
0% |
Olanzapine 2.5 mg Lamotrigine 25 mg |
1 3 |
BAS,
ST, MMF, TAC |
6 |
Psych
Admit 11
days |
C |
49/M Caucasian |
NASH OLT |
40 |
Yes |
Sertraline 50 mg |
75% |
Olanzapine 2.5 mg Sertraline 50 mg |
5 5 |
DAC,
ST, MMF |
14 |
Psych
Admit 12
days |
D |
59/M Caucasian |
HCV/ETOH sLK |
30 |
Yes |
Quetiapine 25 mg Sertraline 50 mg |
95% |
Quetiapine 25 mg Sertraline 50 mg |
0 0 |
BAS,
ST, MMF, TAC |
12 |
Psych
Admit 14
days |
E - I |
64/F Caucasian |
NASH OLT |
29 |
Yes |
None |
0% |
Olanzapine 7.5 mg |
22 |
DAC,
ST, MMF |
29 |
Psych
Admit 5
days |
E - 11 |
Allograft
Ductopenia sLK |
34 |
No |
Olanzapine 10 mg |
0% |
Olanzapine 10 mg |
1 |
BAS,
ST, MMF, TAC |
9 |
Home |
|
F |
56/M Caucasian |
Cryptogenic OLT |
31 |
Yes |
Lithium 900 mg Paroxetine 20 mg |
0% |
Lithium 900 mg Paroxetine 20 mg |
0 0 |
BAS,
ST, MMF, TAC |
7 |
Home |
G |
43/F Caucasian |
PSC/CCA OLT |
24 |
No |
Lamotrigine
300 mg Topiramate 100 mg Venlafaxine
150 mg Ziprasidone 160 mg |
0% |
Lamotrigine 300 mg Topiramate 100 mg Venlafaxine 150 mg Ziprasidone 160 mg |
0 0 0 0 |
DAC,
ST, MMF |
7 |
Home |
H |
58/F Caucasian |
PBC OLT |
26 |
No |
Lithium 600 mg |
0% |
Lithium 600 mg |
5 |
AZA,
ST, MMF, TAC |
7 |
Home |
MELD:
Model of End Stage Liver Disease, HE: Hepatic Encephalopathy, OLT: Orthotopic
Liver Transplant, Meds Medications, POD: Postoperative Day, IMS:
Immunosuppression, LOS: Length of Stay (in days), Psych LOS: psychiatric length
of stay (in days), F: Female, M: Male, HCV: Chronic Hepatitis C, NASH: Nonalcoholic Steatohepatitis, ETOH
alcohol, sLK: Simultaneous Liver and Kidney Transplant, PSC: Primary Sclerosing
Cholangitis, CCA: Cholangiocarcinoma, PBC: Primary Biliary Cirrhosis, BAS:
Basiliximab, ST: Steroids, MMF: Mycophenolate, TAC: Tacrolimus, DAC:
Daclizumab, AZA: Azathioprine, Psych Admit: Psychiatric Admission